<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T20:17:50+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>肿瘤患者福音：K药援助方案再升级，14万兜底保终身！</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/_qOijNTHjs4MZkefV-SuDA</id>
    <link href="https://mp.weixin.qq.com/s/_qOijNTHjs4MZkefV-SuDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>绿叶制药与阿斯利康再度战略携手 积极推进心血管及肿瘤领域的深度合作</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/q_n0QeFc2_pXk3xp7Q-TkQ</id>
    <link href="https://mp.weixin.qq.com/s/q_n0QeFc2_pXk3xp7Q-TkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判独家品种信息汇总（附部分品种降幅）</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/WXtX50ucXF-DwPtcju88YQ</id>
    <link href="https://mp.weixin.qq.com/s/WXtX50ucXF-DwPtcju88YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维迪西妥单抗获CDE突破性治疗认可，有望填补HER2阳性尿路上皮癌治疗空白</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/1cRQr3wudA4KVwhmRj04CQ</id>
    <link href="https://mp.weixin.qq.com/s/1cRQr3wudA4KVwhmRj04CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进医保最快创新药TOP20</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/MoFNFxmKTC0ahhRrkTqOJA</id>
    <link href="https://mp.weixin.qq.com/s/MoFNFxmKTC0ahhRrkTqOJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10个单抗首次医保谈判成功，13个续签</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/3cjhv1c0mXL2FwOlb346dQ</id>
    <link href="https://mp.weixin.qq.com/s/3cjhv1c0mXL2FwOlb346dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大战！6款GLP-1受体激动剂纳入医保目录</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/JyiUKhYPa35JpAKK22cKNg</id>
    <link href="https://mp.weixin.qq.com/s/JyiUKhYPa35JpAKK22cKNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方核心行业数据监测周报（12月19-25日）</title>
    <updated>2020-12-28T17:20:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/AuQ7rFW3UE6Fqc6b6uHkqg</id>
    <link href="https://mp.weixin.qq.com/s/AuQ7rFW3UE6Fqc6b6uHkqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>河南带量采购公布29个品种拟中标结果</title>
    <updated>2020-12-27T10:24:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/f-mxHpIxQZvokpqgGgE_Ow</id>
    <link href="https://mp.weixin.qq.com/s/f-mxHpIxQZvokpqgGgE_Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年具有里程碑意义的临床研究TOP10</title>
    <updated>2020-12-27T10:24:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/ZifFNR9wQGhQFWHaMiC5oA</id>
    <link href="https://mp.weixin.qq.com/s/ZifFNR9wQGhQFWHaMiC5oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，这6家医药公司终止科创板上市</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/cY2GxMfsKmiyvZyxFR9r8Q</id>
    <link href="https://mp.weixin.qq.com/s/cY2GxMfsKmiyvZyxFR9r8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：2020年FDA批准的新药</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/a2KL7BoEMqJDG7rDfcPDtQ</id>
    <link href="https://mp.weixin.qq.com/s/a2KL7BoEMqJDG7rDfcPDtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年失败临床研究TOP10</title>
    <updated>2020-12-26T10:03:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/3LJl_Mt3QhRZZNIhIel6aA</id>
    <link href="https://mp.weixin.qq.com/s/3LJl_Mt3QhRZZNIhIel6aA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和记黄埔「索凡替尼胶囊」即将获批上市</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/DQVx0XnpJTLHv6w9MPHWrw</id>
    <link href="https://mp.weixin.qq.com/s/DQVx0XnpJTLHv6w9MPHWrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重塑SCLC格局、改写NCCN指南！IMpower133试验设计背后的奥秘</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/b7ZkZBZ7FqKQUEhqBzkYbw</id>
    <link href="https://mp.weixin.qq.com/s/b7ZkZBZ7FqKQUEhqBzkYbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>13个品种通过一致性评价，注射用头孢呋辛钠首家过评</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/BD5VxFljt1l3f03pdlLLdA</id>
    <link href="https://mp.weixin.qq.com/s/BD5VxFljt1l3f03pdlLLdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧狄沃患者援助项目再度更新，年自付比例累计降幅超75%</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/aX8cczPKh3Vt4wlbJyCPOA</id>
    <link href="https://mp.weixin.qq.com/s/aX8cczPKh3Vt4wlbJyCPOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国家集采品规资质线上申报工作今日开启</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/QNBh9sIK69Y1DYLHGU3u8w</id>
    <link href="https://mp.weixin.qq.com/s/QNBh9sIK69Y1DYLHGU3u8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药CDK4/6抑制剂SHR6390 片 III 期临床成功</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/21Ss2aCDWGQ5lLnEh7FIEA</id>
    <link href="https://mp.weixin.qq.com/s/21Ss2aCDWGQ5lLnEh7FIEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个药物获批2周年到市值突破1000亿 ，信达是如何做到的？</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/VXU0AWNdFqYQi63dLCiqbw</id>
    <link href="https://mp.weixin.qq.com/s/VXU0AWNdFqYQi63dLCiqbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>